Filing Details
- Accession Number:
- 0001209191-22-061483
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 17:23:04
- Reporting Period:
- 2022-12-08
- Accepted Time:
- 2022-12-15 17:23:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1879223 | Juan Graham | C/O Fibrogen, Inc. 409 Illinois Street San Francisco CA 94158 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-12-08 | 5,263 | $14.84 | 50,628 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-08 | 478 | $15.47 | 50,150 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- These shares were sold in multiple transactions on the reported date with prices ranging from $14.38 to $15.355 resulting in a weighted average price of $14.84. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.